Results 131 to 140 of about 1,771,249 (303)

Backup protection method for half-wavelength transmission lines based on inverse-time characteristic

International Journal of Electrical Power & Energy Systems
The advantages of ultra-high voltage (UHV) Half-wavelength AC transmission (HWACT) technology are achieving full-line reactive power self-balancing without the need for reactive power compensation equipment along the line and avoiding the Ferranti effect.
Hongchun Shu, Lanjie Zhou, Yutao Tang, Yiming Han   +3 more
doaj   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Adaptive reclosing scheme for flexible HVDC grid with single-pole ground fault based on residual voltage zero-crossing detection

International Journal of Electrical Power & Energy Systems
To avoid the issue of blind reclosing in conventional flexible high voltage direct current (HVDC) grid, investigating an adaptive reclosing scheme capable of identifying fault nature and duration is essential.
Yue Dai, Hongchun Shu, Yutao Tang, Feng Gong   +3 more
doaj   +1 more source

Flux pinning in YBa2Cu3O7−δ thin film samples linked to stacking fault density [PDF]

, 2008
Jun Wang, Ji Heon Kwon, Jaesung Yoon, Haiyan Wang, Timothy J. Haugan, F. J. Baca, Neal Pierce, Paul N. Barnes   +7 more
openalex   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Sensor Fault Classification Based on Support Vector Machine and Statistical Time-Domain Features

, 2017
Sana Ullah Jan, Young-Doo Lee, Jungpil Shin, Insoo Koo   +3 more
openalex   +1 more source

PCB-Fire: Automated Classification and Fault Detection in PCB [PDF]

, 2020
Tejas Khare, Vaibhav Bahel, Anuradha C. Phadke   +2 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Visual Process Monitoring by Data-Dependent Kernel Discriminant Analysis with t‑Distributed Similarities

ACS Omega, 2023
Chihang Wei, Chenglin Wen, Jieguang He, Zhihuan Song   +3 more
doaj   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source